Cargando…

Clinical and cranial MRI features of female patients with ornithine transcarbamylase deficiency: Two case reports

INTRODUCTION: Ornithine transcarbamylase deficiency (OTCD) is a common metabolic disease of urea circulation disorder. We reported the clinical, brain imaging and genetic characteristics of 2 cases with OTCD. The patients’ clinical features, novel gene mutations, cranial MR specific imaging changes...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Dan, Lu, Guoyan, Mowshica, Rajah, Cheng, Yan, Zhao, Fumin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831407/
https://www.ncbi.nlm.nih.gov/pubmed/31415401
http://dx.doi.org/10.1097/MD.0000000000016827
_version_ 1783465962452811776
author Yu, Dan
Lu, Guoyan
Mowshica, Rajah
Cheng, Yan
Zhao, Fumin
author_facet Yu, Dan
Lu, Guoyan
Mowshica, Rajah
Cheng, Yan
Zhao, Fumin
author_sort Yu, Dan
collection PubMed
description INTRODUCTION: Ornithine transcarbamylase deficiency (OTCD) is a common metabolic disease of urea circulation disorder. We reported the clinical, brain imaging and genetic characteristics of 2 cases with OTCD. The patients’ clinical features, novel gene mutations, cranial MR specific imaging changes and blood tandem mass spectrometry, and urine gas chromatography-mass spectrometry were, retrospectively, analyzed. PATIENT CONCERNS: Patient 1 was a 1.6-year-old female. She was admitted to the hospital with 2-months history of general irritability and disturbance of consciousness for a day. Patient 2 was a 3.7-year-old female. She was admitted to the hospital due to decline of language ability and irritability for 5 days. Blood tandem mass spectrometry and urine gas chromatography-mass spectrometry showed uracil and orotate increased significantly in urine while amino acids in the urea cycle ring were in the normal range. The features of brain MRI are consistent with those of urea circulatory disorders. Gene detection showed 1 novel mutation in the OTC gene (c.658C>T) in patient 1 and, 1 novel mutation (c.298+2T>G) in the OTC gene in patient 2. DIAGNOSIS: Combined with metabolic screening and gene detection, both patients were diagnosed with OTCD. INTERVENTIONS: The patients’ condition improved after following a low protein diet and receiving treatments for decreasing blood ammonia, energy supplement, correcting acid-base imbalance, and other symptomatic treatments. OUTCOMES: After prompt symptomatic treatment, the consciousness and cognition of the children improved. Besides, liver function also improved significantly. CONCLUSIONS: For patients with neurological symptoms and unexplained increase in transaminase and ammonia, OTCD should be considered as a possible diagnosis. Brain MRI can help the diagnosis of genetic metabolic encephalopathy and reflect the level of brain injury. Metabolic screening and genetic detection are helpful to make a confirmed diagnosis.
format Online
Article
Text
id pubmed-6831407
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-68314072019-11-19 Clinical and cranial MRI features of female patients with ornithine transcarbamylase deficiency: Two case reports Yu, Dan Lu, Guoyan Mowshica, Rajah Cheng, Yan Zhao, Fumin Medicine (Baltimore) 6800 INTRODUCTION: Ornithine transcarbamylase deficiency (OTCD) is a common metabolic disease of urea circulation disorder. We reported the clinical, brain imaging and genetic characteristics of 2 cases with OTCD. The patients’ clinical features, novel gene mutations, cranial MR specific imaging changes and blood tandem mass spectrometry, and urine gas chromatography-mass spectrometry were, retrospectively, analyzed. PATIENT CONCERNS: Patient 1 was a 1.6-year-old female. She was admitted to the hospital with 2-months history of general irritability and disturbance of consciousness for a day. Patient 2 was a 3.7-year-old female. She was admitted to the hospital due to decline of language ability and irritability for 5 days. Blood tandem mass spectrometry and urine gas chromatography-mass spectrometry showed uracil and orotate increased significantly in urine while amino acids in the urea cycle ring were in the normal range. The features of brain MRI are consistent with those of urea circulatory disorders. Gene detection showed 1 novel mutation in the OTC gene (c.658C>T) in patient 1 and, 1 novel mutation (c.298+2T>G) in the OTC gene in patient 2. DIAGNOSIS: Combined with metabolic screening and gene detection, both patients were diagnosed with OTCD. INTERVENTIONS: The patients’ condition improved after following a low protein diet and receiving treatments for decreasing blood ammonia, energy supplement, correcting acid-base imbalance, and other symptomatic treatments. OUTCOMES: After prompt symptomatic treatment, the consciousness and cognition of the children improved. Besides, liver function also improved significantly. CONCLUSIONS: For patients with neurological symptoms and unexplained increase in transaminase and ammonia, OTCD should be considered as a possible diagnosis. Brain MRI can help the diagnosis of genetic metabolic encephalopathy and reflect the level of brain injury. Metabolic screening and genetic detection are helpful to make a confirmed diagnosis. Wolters Kluwer Health 2019-08-16 /pmc/articles/PMC6831407/ /pubmed/31415401 http://dx.doi.org/10.1097/MD.0000000000016827 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 6800
Yu, Dan
Lu, Guoyan
Mowshica, Rajah
Cheng, Yan
Zhao, Fumin
Clinical and cranial MRI features of female patients with ornithine transcarbamylase deficiency: Two case reports
title Clinical and cranial MRI features of female patients with ornithine transcarbamylase deficiency: Two case reports
title_full Clinical and cranial MRI features of female patients with ornithine transcarbamylase deficiency: Two case reports
title_fullStr Clinical and cranial MRI features of female patients with ornithine transcarbamylase deficiency: Two case reports
title_full_unstemmed Clinical and cranial MRI features of female patients with ornithine transcarbamylase deficiency: Two case reports
title_short Clinical and cranial MRI features of female patients with ornithine transcarbamylase deficiency: Two case reports
title_sort clinical and cranial mri features of female patients with ornithine transcarbamylase deficiency: two case reports
topic 6800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831407/
https://www.ncbi.nlm.nih.gov/pubmed/31415401
http://dx.doi.org/10.1097/MD.0000000000016827
work_keys_str_mv AT yudan clinicalandcranialmrifeaturesoffemalepatientswithornithinetranscarbamylasedeficiencytwocasereports
AT luguoyan clinicalandcranialmrifeaturesoffemalepatientswithornithinetranscarbamylasedeficiencytwocasereports
AT mowshicarajah clinicalandcranialmrifeaturesoffemalepatientswithornithinetranscarbamylasedeficiencytwocasereports
AT chengyan clinicalandcranialmrifeaturesoffemalepatientswithornithinetranscarbamylasedeficiencytwocasereports
AT zhaofumin clinicalandcranialmrifeaturesoffemalepatientswithornithinetranscarbamylasedeficiencytwocasereports